Plasma Peptidome Profiling in Acute Hepatitis E Patients
Author Information
Author(s): Taneja Shikha, Ahmad Imran, Sen Somdutta, Kumar Saravanan, Arora Reena, Gupta Vijay K, Aggarwal Rakesh, Narayanasamy Krishnamoorthy, Reddy Vanga S, Jameel Shahid
Primary Institution: International Centre for Genetic Engineering and Biotechnology
Hypothesis
Profiling the plasma peptidome from hepatitis E patients can help discover suitable biomarkers and understand disease pathogenesis.
Conclusion
The study identified five potential biomarker peaks that can reliably distinguish hepatitis E patients from healthy controls.
Supporting Evidence
- Five potential biomarker peaks were identified with high AUROC values.
- Peptides involved in innate immunity were differentially present in patients compared to controls.
- The study used a magnetic bead-based separation strategy for peptide enrichment.
- Mass spectrometry analysis revealed distinct peptide patterns between patients and healthy controls.
- Statistical tests indicated significant differences in peptide profiles.
Takeaway
Researchers looked at blood samples from hepatitis E patients to find special markers that can help tell if someone has the disease.
Methodology
Mass spectrometry was used to analyze the plasma peptidome of hepatitis E patients compared to healthy controls.
Potential Biases
The findings may not be generalizable to other forms of hepatitis or to female patients.
Limitations
The study only included male patients and used a method that captures only hydrophobic peptides.
Participant Demographics
All participants were male with a mean age of 31 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI = 0.890-1.000
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website